Anti-Infectives

The consequences of  AMR (Antimicrobial Resistance) on health, healthcare system and its economic burden are extraordinary. It has been estimated that multidrug resistant infections cause approximately 700,000 deaths worldwide each year. This number is likely to be underestimated due to poor reporting and surveillance. By 2050 it is projected that, unless action is taken, the burden of deaths from AMR could reach 10 million lives each year globally with $100 trillion GDP loss up to 2050.

By treating and preventing infections, antimicrobial medicines have enabled unique medical advances that appear as routine today - including chemotherapy, complex surgeries, and organ transplants, and the care of preterm infants and immunocompromised patients.

AMR is progressively undermining the viability of several types of medical interventions leaving patients highly vulnerable to resistant infections.

In the US, today more than two million infections per year are caused by bacteria that are resistant to at least first-line antibiotic treatments, costing the US health system 20 billion $ in excess costs each year.

In the EU, each year antibiotic resistance is responsible for about 33,000 deaths with an economic burden of about €1.1 billion for the health care systems.

(ref. WHO website)